The global pharmaceutical filtration market is segmented on the basis of product, technique, application, scale of operation, and region. On the basis of product, the pharmaceutical filtration market is segmented into membrane filters, prefilters and depth media filters, cartridge & capsule filters, single-use systems, filter holders, filtration accessories, and other products. In 2016, the membrane filters segment accounted for the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period. The key factor driving the growth of the membrane filters segment is the ease of installation in large and small manufacturing facilities owing to the availability of a variety of pore and surface types.

Browse 87 market data tables and 36 figures spread through 164 pages and in-depth TOC on “Pharmaceutical Filtration Market“.

http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html

Based on application, the final product-processing segment is expected to register the highest CAGR during the forecast period owing to the rapidly growing biologics and generic drug production coupled with the presence of stringent regulatory guidelines to maintain a clean and safe manufacturing environment.

Based on technique, the microfiltration segment dominated this market in 2016. The technique is applied to various applications ranging from the removal of unwanted suspensions to the removal of bacteria from the process material. This is the major factor responsible for the large share of this segment.

Based on scale of operation, the manufacturing scale segment is expected to register the highest growth during the forecast period. The high growth in this segment can primarily be attributed to the growth in the biopharmaceutical industry coupled with the outsourcing of pharmaceutical and biopharmaceutical production in emerging countries.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=209343847

Asia is expected to register the highest CAGR during the forecast period. Growing biopharmaceutical industry and the rise in contract research and manufacturing organizations in emerging Asian countries are the key factors driving the growth of the Asian market.

The key players can leverage the evident growth opportunities in emerging markets by adopting organic growth strategies such as expansions and inorganic strategies of agreements and collaborations with various research institutes.